https://eureka.patsnap.com/resources/blog/rd-blog/spatial-multiomics-integration-patent-landscape/ · Patsnap · data cut-off 2026-07-31 · downloaded from the live page
Patent Landscape · Spatial Multiomics Integration
Spatial multiomics integration patents: who holds the joint-profiling claims and where they thin out
  • 17 filings in 2023, the peak year so far, against a field of only 32 published records total — this is a young, still-consolidating claim set.
  • One assignee reaches 21 records while fifth place holds just 2, so the ranking has a single dominant filer above a long tail of single- and double-digit entrants.
  • Protein-recoding claims sit at the top of the citation table, with the most-cited family drawing 7 citations for reframing amino-acid sequence readout as a DNA-polymer measurement problem.
Get a prior-art report on your approach
32
Published Records
US
Leading Jurisdiction
21
Active Filers Ranked
2023
Peak Filing Year

Published byPatsnap Research··7 min readSourced from Patsnap Eureka
Field Overview

What spatial multiomics integration patents actually cover

Spatial multiomics integration sits at the intersection of tissue-section imaging, molecular barcoding and computational alignment: methods for reading out multiple molecular layers — DNA, RNA, protein — from the same tissue section and then registering those readouts against one another and against physical position. The claim language in this dataset clusters around two mechanics: how the assay converts a biological signal into a measurable format (recoding protein sequence into DNA, barcoding macromolecules inside individual cells) and how sparse, multi-modal measurements get reconciled across sections, cells and assay runs. Sample throughput, assay compatibility and cross-modality alignment are recurring claim elements rather than background language, which is why this search string surfaces a narrow, technically coherent set of 32 records rather than a broad omics dump.

Filing activity is concentrated in a short window, peaking at 17 records in 2023, and publication lag means the last one to two years understate true filing volume. The assignee base is small and unevenly distributed: one organisation accounts for 21 of the ranked records, while most others appear once or twice, which points to a field still being staked out rather than one with settled competitive lines.

Filing activity by year (2017–2026, most recent year partial)
  1. 1ABRUS BIO INC21
  2. 2ENCODIA INC7
  3. 3THE BROAD INST INC2
  4. 4THE GENERAL HOSPITAL CORP2
  5. 5MASSACHUSETTS INST OF TECH2
  6. 6TRUSTEES OF DARTMOUTH COLLEGE THE2
  7. 7MT SINAI SCHOOL OF MEDICINE2
  8. 8NORTHWESTERN UNIV2
  9. 9ZHANG ZIDONG1
  10. 10CHIKINA MARIA1
Source: Patsnap Eureka. Assignee ranking and totals. Derived from a Patsnap search on Spatial Multiomics Integration covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Let an AI agent run this analysis on your own technology

Pick a task. Every answer cites the patents behind it.

10,000 free credits to start
Filing & Classification Data

Filing trend and technology composition

The 32 records in scope split across eight IPC subclasses and six receiving offices, with the United States taking the largest single share of filings and G01N and C12Q covering the majority of records between them.

A short, sharp filing window

Filings were essentially absent before the field's technical vocabulary matured, rose to a peak of 17 in 2023, and the most recent year is necessarily undercounted because publication runs roughly 18 months behind filing.

A short, sharp filing window0510152002017201820192020202120221720232024202502026Most recent year is partial — publication lag means later filings are not yet visible.

Assay measurement and DNA/enzyme testing dominate

G01N (material analysis and testing) appears in 59.4% of the 32 records and C12Q (enzyme/DNA-based measurement) in 56.3%, together forming the technical core; combinatorial library methods under C40B reach 21.9%, while bioinformatics-specific claims under G16B sit at just 6.3% of records, a small share for a field whose value depends on computational cross-modality alignment.

Assay measurement and DNA/enzyme testing dominateG01N · Material analysis & testing1959.4%C12Q · Measuring & testing involving …1856.3%C40B · Combinatorial chemistry librar…721.9%C12N · Microorganisms & genetic engin…39.4%A61K · Medicinal preparations26.3%G16B · Bioinformatics26.3%A61P · Therapeutic activity of compou…13.1%C07K · Peptides & proteins13.1%

Shares are the percentage of the 32 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.

Source: Patsnap Eureka. Filing trend and technology composition. Derived from a Patsnap search on Spatial Multiomics Integration covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.

Go deeper on Spatial Multiomics Integration with Eureka

This page is one run against one query. Ask Eureka your own question about spatial multiomics integration and every answer comes back with the patent numbers behind it.

Try Eureka
Key Patents

The most-cited records in the field

Representative Recent Filing
US20260034249A12026-02-05

Compositions and methods for modifying fertility (US20260034249A1)

THE BROAD INSTITUTE, INC.

The present disclosure features methods for modifying fertility. In some embodiments, the disclosure provides contraceptive compositions and methods of using the same.Filed by The Broad Institute, Inc.; published 2026-02-05. Its presence in this dataset reflects the shared molecular-profiling and modality toolkit rather than a therapeutic-fertility focus.

US20260034249A1 — patent drawing 1US20260034249A1 — patent drawing 2
View full filing
Highest-cited published records in scope
#Publication no.Patent titleCitations
1WO2024015875A2Determination of protein information by recoding amino acid polymers into DNA polymers7
2US20250020657A1Determination of protein information by recoding amino acid polymers into DNA polymers6
3US12188940B2Determination of protein information by recoding amino acid polymers into DNA polymers6
4US20230332215A1Methods for barcoding macromolecules in individual cells5
5WO2024040236A2Determination of protein information by recoding amino acid polymers into DNA polymers4
6US20240044909A1Determination of protein information by recoding amino acid polymers into DNA polymers4
7WO2024050541A1Systems and methods for diagnosing a disease or a condition3
8US12038443B2Determination of protein information by recoding amino acid polymers into DNA polymers3
9WO2023086847A1Methods for barcoding macromolecules in individual cells3
10US20230143290A1Methods for barcoding macromolecules in individual cells3

Citation counts are drawn from a searched corpus and favour older, earlier-published records; treat them as a signal of influence on later filings, not as a measure of current commercial importance.

Each row carries its publication number; clicking a row searches Eureka by that number.

Source: Patsnap Eureka. Citation counts and representative records. Derived from a Patsnap search on Spatial Multiomics Integration covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Run it yourself

Put your own technology through the same analysis


  
Where to run it
Fastest

Eureka on the web

When you want the answer in the next five minutes.

The agent works the prompt against patents and technical literature, citing every source.

Run your analysis now →
For builders

MCP server & REST API

When it has to run inside your own pipeline.

Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.

Browse MCP servers →
Signal & Interpretation

What the numbers mean for a filing decision

Three patterns stand out once family counts, citation concentration and classification shares are read together.

Concentration
21 vs 2
leader vs fifth place, in records

One filer, then a long tail

The leading assignee holds 21 of the ranked records; fifth place holds only 2. That gap is wide enough that a new entrant is not really contesting a crowded middle field, but deciding whether to file adjacent to a single dominant portfolio or to look elsewhere entirely.

Assignee ranking, 21 companies
Citation Weight
7 citations
on the top-cited family

Protein-recoding claims carry the most influence

The most-cited record and its related family members all describe recoding amino-acid polymer information into DNA polymers for readout — a mechanic that later filings appear to cite repeatedly, making it the closest thing this dataset has to a foundational claim.

Most-cited records table
Classification Gap
6.3%
of 32 records under G16B (bioinformatics)

Computational alignment is under-claimed relative to assay mechanics

Assay-side classes (G01N, C12Q, C40B) cover the bulk of records, but bioinformatics-specific claims sit at only 6.3% of the 32 records. For a field defined by reconciling sparse multi-modal signals, the computational-alignment layer looks thinly staked.

IPC composition, 32 records in scope
Eureka AI Agent
Looking for what nobody has claimed yet?

Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to spatial multiomics integration, with the prior art for and against each one.

Find the white space →
Source: Patsnap Eureka. Co-assignee relationships and derived observations. Derived from a Patsnap search on Spatial Multiomics Integration covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Competitive Landscape

Who is filing, and where the field is still open

The ranked assignee list is short — 21 organisations in total — and dominated by academic and research institutions rather than diagnostics or platform companies, with momentum for every tracked assignee flat or down in the latest year once publication lag is accounted for.

Leader
21 records
held by the top-ranked assignee

A single research-institute portfolio anchors the field

One organisation's filings account for the large majority of the ranked activity, spanning protein-recoding and macromolecule-barcoding methods. Co-assignee pairings in the dataset also route back to this same organisation working alongside other research institutions.

Assignee ranking
Long Tail
2 records
at fifth place in the ranking

Most other filers appear once or twice

Beyond the leader, filing counts drop off quickly — fifth place holds only 2 records and tenth place just 1. This is typical of a field still in an exploratory phase, where individual labs and small entities stake narrow method claims rather than building broad portfolios.

Assignee ranking, 21 companies
Collaboration
10 pairs
co-assignee pairings identified

Filings cluster through institutional partnerships

Ten co-assignee pairs appear in the dataset, several repeating around the same lead institution paired with different partner universities and hospitals — evidence of shared research programmes rather than independent competing filings.

Co-assignee pair analysis
🔍
Under-claimed sub-areas worth watching
Branches with thin IPC coverage relative to the field's core assay mechanics
cross-modality alignment algorithmssection registration for serial tissue slicesmeasurement-sparsity correction methodsassay-compatibility validation protocolsbioinformatics pipelines for joint profiling
Rank all filers by momentum →
Recent-year momentum across tracked assignees
AssigneeRecent yearYoY
Abrus Bio, Inc.0-100%
Encodia, Inc.0-100%
Massachusetts Institute of Technology0-100%
The General Hospital Corporation0-100%
Trustees of Dartmouth College0-100%
Icahn School of Medicine at Mount Sinai0—
Northwestern University0-100%
The Broad Institute, Inc.0-100%
Source: Patsnap Eureka. Assignee-level momentum. Derived from a Patsnap search on Spatial Multiomics Integration covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Next Steps

Where to take this analysis

The figures above describe what has been filed; the next step is testing a specific claim or design-around against the full family text.

Check freedom-to-operate against the top-cited family

The protein-recoding-to-DNA-polymer claims cited most often in this dataset are a natural starting point for a freedom-to-operate check before committing to a similar readout mechanic.

Explore this family in Eureka

Map the white space before drafting new claims

Bioinformatics and cross-modality alignment classes are thinly represented relative to assay-mechanics classes; a claim drafted in that gap may face less prior art.

Run a white-space search in Eureka

Track the leading portfolio's filing pattern

With one assignee holding 21 of 32 ranked records, watching its continuation and new-filing activity is a reasonable proxy for where the field's centre of gravity moves next.

Monitor this assignee in Eureka
Source: Patsnap Eureka. Forward-looking reading of the same dataset. Derived from a Patsnap search on Spatial Multiomics Integration covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
FAQ

Common questions about spatial multiomics integration patents

Answers are grounded in the same dataset. Derived from a Patsnap search on Spatial Multiomics Integration covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Research Spatial Multiomics Integration in depth with Eureka

Go past this page: query the whole spatial multiomics integration corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.

Try Eureka

Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.

Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.

Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.

Help us improve

Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.